Marinus Pharmaceuticals (NASDAQ:MRNS) Price Target Raised to $21.00 at Royal Bank of Canada theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Marinus Pharmaceuticals to Present at the 2023 Cantor Global Healthcare Conference streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
RADNOR - Marinus Pharmaceuticals, Inc. , a pharmaceutical company dedicated to the development of innovative therapeutics to treat seizure disorders, is today hosting an Investor and Analyst Event in.
By Denny Jacob Marinus Pharmaceuticals shares rose 16% to $6.83 following news the company extended its cash runway into the fourth quarter. The stock is up.